Abstract
We report the successful and safe use of levosimendan, a new calcium-sensitizing agent with positive inotropic and vasodilatory action, in 2 critically ill term newborns with acute heart failure and pulmonary hypertension in the absence of any underlying heart malformation and/or previous cardiosurgical procedures. During the neonatal period, levosimendan may represent an ideal drug for immature myocardium characterized by a higher calcium-dependent contractility than in adults.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 201-205 |
Numero di pagine | 5 |
Rivista | Neonatology |
Volume | 101 |
Numero di pubblicazione | 3 |
DOI | |
Stato di pubblicazione | Pubblicato - 2012 |
All Science Journal Classification (ASJC) codes
- Pediatria, Perinatologia e Salute del Bambino
- Biologia dello Sviluppo
Keywords
- Heart failure
- Levosimendan
- Pulmonary hypertension